The University of California’s two nationally ranked medical centers, UCLA and UCSF, have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates lesions in the pelvic area and other parts of the body to which the tumors have migrated, it was announced Tuesday. Known […]